Digitisation | March 18, 2023
Lupin Digital Health reveals results of digital therapeutics study with ACS patients
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
A funding to expand operations and provide better patient care
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
This artificial RNA ligase has higher thermostability than natural RNA ligase
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Subscribe To Our Newsletter & Stay Updated
